Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11672762 Onapristone extended-release compositions and methods

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 13, 2023

0

Patent Application Number

170355440

Date Filed

September 28, 2020

0

Patent Citations

US Patent 9046534 Methods and systems for identifying and treating anti-progestin sensitive tumors

0

US Patent 9074002 PTP1B inhibitors

0

US Patent 9328346 Polycomb-associated non-coding RNAs

0

US Patent 9193757 Onapristone polymorphic forms and methods of use

0

US Patent 9618512 Biomarker for breast cancer

0

US Patent 7678781 11-phosphorous steroid derivatives useful as progesterone receptor modulators

0

US Patent 8121365 Method and system for determining an optimal dilution of a reagent

0

Patent Primary Examiner

Genevieve S Alley

0

CPC Code

0

0

0

Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11672762 Onapristone extended-release compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool